Global Clinical Risk Grouping Solutions Market

Clinical Risk Grouping Solutions Comprehensive Study by Type (Scorecard and Visualization Tools, Dashboard Analysis, Risk Report), End Users (Hospitals, Payers, Ambulatory Care Centers, Long- Term Care Centers), Deployment Model (Private Cloud, Public Cloud, Hybrid Cloud) Players and Region - Global Market Outlook to 2030

Clinical Risk Grouping Solutions Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 13.14%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Clinical Risk Grouping Solutions
Clinical Risk Grouping Solutions are systems used to manage risk-adjusted capitation-based payment and health care management. It is used by healthcare service providers to perform daily living activities. These solutions assign each individual to a single mutually exclusive risk group which relates the historical clinical and demographic characteristics to predict future use of healthcare resources. The demand for dashboard and data visualization tools in hospitals and clinics is anticipated to boost the market growth rate in upcoming years.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR13.14%


A vast client base of the healthcare industry makes it possible for providers of clinical risk grouping solutions to cater to a large market and earn profits. The introduction and adoption of new technologies is attracting more customers. The key players are focusing on new product launches, partnership, acquisition, and geographical expansion strategies Analyst at AMA Research estimates that United States and European Players will contribute the maximum growth to Global Clinical Risk Grouping Solutions market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

3M Corporation (United States), Optum Inc. (United States), Cerner Corporation (United States), Conduent Inc. (United States), Nuance Communications (United States), Health Catalyst (United States), HBI Solutions (United States), Johns Hopkins University (United States), Lightbeam Health Solutions (United States), Dynamic Healthcare Systems (United States), 4S Information Systems (United States), Evolent Health (United States) and Pera Health (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Clinical Risk Grouping Solutions market by Type (Scorecard and Visualization Tools, Dashboard Analysis and Risk Report) and Region.



On the basis of geography, the market of Clinical Risk Grouping Solutions has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users , the sub-segment i.e. Hospitals will boost the Clinical Risk Grouping Solutions market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Deployment Model, the sub-segment i.e. Private Cloud will boost the Clinical Risk Grouping Solutions market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Emergence Of Big Data Solutions

Market Growth Drivers:
Increasing Adoption of Risk Reporting Solutions By Healthcare Providers and Growing Investments In R&D Of New Therapeutics

Challenges:
Scarcity of Skilled Healthcare IT Professionals

Restraints:
Lack of Infrastructure and High Cost Related to Clinical Solutions

Opportunities:
Increasing Physician Burnout Due to Documentation Needs and Adoption of Artificial Intelligence (AI) and Machine Learning

Market Leaders and their expansionary development strategies
In June 2019, Optum, Inc. acquired the DaVita Medical Group, an independent medical groups. This acquisition enables Optum to provide improved care quality and patient experiences and lower costs for 16 million people, especially for kidney care space.
In April 2022, Tata Consultancy Services has launched an agile and intuitive risk-based monitoring solution for clinical trials, that enables intelligent decision making, increased compliance and improves study efficacy.the new risk-based monitoring solution enables biopharmaceutical and Contract Research Organizations (CROs) to identify study and site risks through advanced statistical algorithms and drive intelligent data driven decisions.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Clinical Risk Grouping Solutions Providers, Cloud Service Providers, Government Regulatory, Research Organizations and End Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Scorecard and Visualization Tools
  • Dashboard Analysis
  • Risk Report
By End Users
  • Hospitals
  • Payers
  • Ambulatory Care Centers
  • Long- Term Care Centers

By Deployment Model
  • Private Cloud
  • Public Cloud
  • Hybrid Cloud

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Risk Reporting Solutions By Healthcare Providers
      • 3.2.2. Growing Investments In R&D Of New Therapeutics
    • 3.3. Market Challenges
      • 3.3.1. Scarcity of Skilled Healthcare IT Professionals
    • 3.4. Market Trends
      • 3.4.1. Emergence Of Big Data Solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Risk Grouping Solutions, by Type, End Users , Deployment Model and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Clinical Risk Grouping Solutions (Value)
      • 5.2.1. Global Clinical Risk Grouping Solutions by: Type (Value)
        • 5.2.1.1. Scorecard and Visualization Tools
        • 5.2.1.2. Dashboard Analysis
        • 5.2.1.3. Risk Report
      • 5.2.2. Global Clinical Risk Grouping Solutions by: Deployment Model (Value)
        • 5.2.2.1. Private Cloud
        • 5.2.2.2. Public Cloud
        • 5.2.2.3. Hybrid Cloud
      • 5.2.3. Global Clinical Risk Grouping Solutions Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Clinical Risk Grouping Solutions: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Optum Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cerner Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Conduent Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nuance Communications (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Health Catalyst (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. HBI Solutions (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Johns Hopkins University (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lightbeam Health Solutions (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dynamic Healthcare Systems (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. 4S Information Systems (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Evolent Health (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Pera Health (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Clinical Risk Grouping Solutions Sale, by Type, End Users , Deployment Model and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Clinical Risk Grouping Solutions (Value)
      • 7.2.1. Global Clinical Risk Grouping Solutions by: Type (Value)
        • 7.2.1.1. Scorecard and Visualization Tools
        • 7.2.1.2. Dashboard Analysis
        • 7.2.1.3. Risk Report
      • 7.2.2. Global Clinical Risk Grouping Solutions by: Deployment Model (Value)
        • 7.2.2.1. Private Cloud
        • 7.2.2.2. Public Cloud
        • 7.2.2.3. Hybrid Cloud
      • 7.2.3. Global Clinical Risk Grouping Solutions Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Risk Grouping Solutions: by Type(USD Million)
  • Table 2. Clinical Risk Grouping Solutions Scorecard and Visualization Tools , by Region USD Million (2018-2023)
  • Table 3. Clinical Risk Grouping Solutions Dashboard Analysis , by Region USD Million (2018-2023)
  • Table 4. Clinical Risk Grouping Solutions Risk Report , by Region USD Million (2018-2023)
  • Table 5. Clinical Risk Grouping Solutions: by Deployment Model(USD Million)
  • Table 6. Clinical Risk Grouping Solutions Private Cloud , by Region USD Million (2018-2023)
  • Table 7. Clinical Risk Grouping Solutions Public Cloud , by Region USD Million (2018-2023)
  • Table 8. Clinical Risk Grouping Solutions Hybrid Cloud , by Region USD Million (2018-2023)
  • Table 9. South America Clinical Risk Grouping Solutions, by Country USD Million (2018-2023)
  • Table 10. South America Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 11. South America Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 12. South America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 13. Brazil Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 14. Brazil Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 15. Brazil Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 16. Argentina Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 17. Argentina Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 18. Argentina Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 19. Rest of South America Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 20. Rest of South America Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 21. Rest of South America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 22. Asia Pacific Clinical Risk Grouping Solutions, by Country USD Million (2018-2023)
  • Table 23. Asia Pacific Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 24. Asia Pacific Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 25. Asia Pacific Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 26. China Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 27. China Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 28. China Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 29. Japan Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 30. Japan Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 31. Japan Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 32. India Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 33. India Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 34. India Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 35. South Korea Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 36. South Korea Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 37. South Korea Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 38. Taiwan Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 39. Taiwan Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 40. Taiwan Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 41. Australia Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 42. Australia Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 43. Australia Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 44. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 45. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 46. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 47. Europe Clinical Risk Grouping Solutions, by Country USD Million (2018-2023)
  • Table 48. Europe Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 49. Europe Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 50. Europe Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 51. Germany Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 52. Germany Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 53. Germany Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 54. France Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 55. France Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 56. France Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 57. Italy Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 58. Italy Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 59. Italy Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 60. United Kingdom Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 61. United Kingdom Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 62. United Kingdom Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 63. Netherlands Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 64. Netherlands Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 65. Netherlands Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 66. Rest of Europe Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 67. Rest of Europe Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 68. Rest of Europe Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 69. MEA Clinical Risk Grouping Solutions, by Country USD Million (2018-2023)
  • Table 70. MEA Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 71. MEA Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 72. MEA Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 73. Middle East Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 74. Middle East Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 75. Middle East Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 76. Africa Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 77. Africa Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 78. Africa Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 79. North America Clinical Risk Grouping Solutions, by Country USD Million (2018-2023)
  • Table 80. North America Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 81. North America Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 82. North America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 83. United States Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 84. United States Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 85. United States Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 86. Canada Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 87. Canada Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 88. Canada Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 89. Mexico Clinical Risk Grouping Solutions, by Type USD Million (2018-2023)
  • Table 90. Mexico Clinical Risk Grouping Solutions, by End Users USD Million (2018-2023)
  • Table 91. Mexico Clinical Risk Grouping Solutions, by Deployment Model USD Million (2018-2023)
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Clinical Risk Grouping Solutions: by Type(USD Million)
  • Table 106. Clinical Risk Grouping Solutions Scorecard and Visualization Tools , by Region USD Million (2025-2030)
  • Table 107. Clinical Risk Grouping Solutions Dashboard Analysis , by Region USD Million (2025-2030)
  • Table 108. Clinical Risk Grouping Solutions Risk Report , by Region USD Million (2025-2030)
  • Table 109. Clinical Risk Grouping Solutions: by Deployment Model(USD Million)
  • Table 110. Clinical Risk Grouping Solutions Private Cloud , by Region USD Million (2025-2030)
  • Table 111. Clinical Risk Grouping Solutions Public Cloud , by Region USD Million (2025-2030)
  • Table 112. Clinical Risk Grouping Solutions Hybrid Cloud , by Region USD Million (2025-2030)
  • Table 113. South America Clinical Risk Grouping Solutions, by Country USD Million (2025-2030)
  • Table 114. South America Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 115. South America Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 116. South America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 117. Brazil Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 118. Brazil Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 119. Brazil Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 120. Argentina Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 121. Argentina Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 122. Argentina Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 123. Rest of South America Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 124. Rest of South America Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 125. Rest of South America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 126. Asia Pacific Clinical Risk Grouping Solutions, by Country USD Million (2025-2030)
  • Table 127. Asia Pacific Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 128. Asia Pacific Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 129. Asia Pacific Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 130. China Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 131. China Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 132. China Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 133. Japan Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 134. Japan Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 135. Japan Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 136. India Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 137. India Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 138. India Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 139. South Korea Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 140. South Korea Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 141. South Korea Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 142. Taiwan Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 143. Taiwan Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 144. Taiwan Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 145. Australia Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 146. Australia Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 147. Australia Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 148. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 149. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 150. Rest of Asia-Pacific Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 151. Europe Clinical Risk Grouping Solutions, by Country USD Million (2025-2030)
  • Table 152. Europe Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 153. Europe Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 154. Europe Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 155. Germany Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 156. Germany Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 157. Germany Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 158. France Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 159. France Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 160. France Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 161. Italy Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 162. Italy Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 163. Italy Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 164. United Kingdom Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 165. United Kingdom Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 166. United Kingdom Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 167. Netherlands Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 168. Netherlands Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 169. Netherlands Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 170. Rest of Europe Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 171. Rest of Europe Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 172. Rest of Europe Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 173. MEA Clinical Risk Grouping Solutions, by Country USD Million (2025-2030)
  • Table 174. MEA Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 175. MEA Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 176. MEA Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 177. Middle East Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 178. Middle East Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 179. Middle East Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 180. Africa Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 181. Africa Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 182. Africa Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 183. North America Clinical Risk Grouping Solutions, by Country USD Million (2025-2030)
  • Table 184. North America Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 185. North America Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 186. North America Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 187. United States Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 188. United States Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 189. United States Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 190. Canada Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 191. Canada Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 192. Canada Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 193. Mexico Clinical Risk Grouping Solutions, by Type USD Million (2025-2030)
  • Table 194. Mexico Clinical Risk Grouping Solutions, by End Users USD Million (2025-2030)
  • Table 195. Mexico Clinical Risk Grouping Solutions, by Deployment Model USD Million (2025-2030)
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Risk Grouping Solutions: by Type USD Million (2018-2023)
  • Figure 5. Global Clinical Risk Grouping Solutions: by Deployment Model USD Million (2018-2023)
  • Figure 6. South America Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 7. Asia Pacific Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 8. Europe Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 9. MEA Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 10. North America Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 11. Global Clinical Risk Grouping Solutions share by Players 2023 (%)
  • Figure 12. Global Clinical Risk Grouping Solutions share by Players (Top 3) 2023(%)
  • Figure 13. Global Clinical Risk Grouping Solutions share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. 3M Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. 3M Corporation (United States) Revenue: by Geography 2023
  • Figure 17. Optum Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Optum Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cerner Corporation (United States) Revenue: by Geography 2023
  • Figure 21. Conduent Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Conduent Inc. (United States) Revenue: by Geography 2023
  • Figure 23. Nuance Communications (United States) Revenue, Net Income and Gross profit
  • Figure 24. Nuance Communications (United States) Revenue: by Geography 2023
  • Figure 25. Health Catalyst (United States) Revenue, Net Income and Gross profit
  • Figure 26. Health Catalyst (United States) Revenue: by Geography 2023
  • Figure 27. HBI Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 28. HBI Solutions (United States) Revenue: by Geography 2023
  • Figure 29. Johns Hopkins University (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johns Hopkins University (United States) Revenue: by Geography 2023
  • Figure 31. Lightbeam Health Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 32. Lightbeam Health Solutions (United States) Revenue: by Geography 2023
  • Figure 33. Dynamic Healthcare Systems (United States) Revenue, Net Income and Gross profit
  • Figure 34. Dynamic Healthcare Systems (United States) Revenue: by Geography 2023
  • Figure 35. 4S Information Systems (United States) Revenue, Net Income and Gross profit
  • Figure 36. 4S Information Systems (United States) Revenue: by Geography 2023
  • Figure 37. Evolent Health (United States) Revenue, Net Income and Gross profit
  • Figure 38. Evolent Health (United States) Revenue: by Geography 2023
  • Figure 39. Pera Health (United States) Revenue, Net Income and Gross profit
  • Figure 40. Pera Health (United States) Revenue: by Geography 2023
  • Figure 41. Global Clinical Risk Grouping Solutions: by Type USD Million (2025-2030)
  • Figure 42. Global Clinical Risk Grouping Solutions: by Deployment Model USD Million (2025-2030)
  • Figure 43. South America Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 44. Asia Pacific Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 45. Europe Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 46. MEA Clinical Risk Grouping Solutions Share (%), by Country
  • Figure 47. North America Clinical Risk Grouping Solutions Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M Corporation (United States)
  • Optum Inc. (United States)
  • Cerner Corporation (United States)
  • Conduent Inc. (United States)
  • Nuance Communications (United States)
  • Health Catalyst (United States)
  • HBI Solutions (United States)
  • Johns Hopkins University (United States)
  • Lightbeam Health Solutions (United States)
  • Dynamic Healthcare Systems (United States)
  • 4S Information Systems (United States)
  • Evolent Health (United States)
  • Pera Health (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 232 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clinical Risk Grouping Solutions Market Quantitative research analysis
Global Clinical Risk Grouping Solutions Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as 3M Corporation (United States), Optum Inc. (United States), Cerner Corporation (United States), Conduent Inc. (United States), Nuance Communications (United States), Health Catalyst (United States), HBI Solutions (United States), Johns Hopkins University (United States), Lightbeam Health Solutions (United States), Dynamic Healthcare Systems (United States), 4S Information Systems (United States), Evolent Health (United States) and Pera Health (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Emergence Of Big Data Solutions" is seen as one of major influencing trends for Clinical Risk Grouping Solutions Market during projected period 2023-2030.
The Clinical Risk Grouping Solutions market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Clinical Risk Grouping Solutions Market Report?

Have a Query? Click Here

Other Related Reports

AI for Pharma and Biotech Comprehensive Study by Type (Deep Learning, Big Data, Image Detection), Application (Hospital, Clinic, Research Center, Academic & Government Institutes, Others), End Use (D...
$ 3650
Kidney Function Tests Comprehensive Study by Type (Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests), Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate T...
$ 3650
Breast Imaging Technology Comprehensive Study by Type (Ionizing Breast Imaging Technologies (Mammography (FFDM, Digital & 3D Mammography), PEM, PET-CT, MBI/BSGI, CBCT), Non-ionizing Breast Imaging Te...
$ 3750
Stroke Post Processing Software Comprehensive Study by Type (Ischemic Stroke, Hemorrhagic Stroke, Others), Installation (Desktops, Mobile Phones, Tablets), End-Use (Diagnostic Centers, Hospitals, Amb...
$ 3450
Heart-on-a-chip Comprehensive Study by Type (Children Heart-on-a-chip, Adult Heart-on-a-chip), Application (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users) ...
$ 3500
Nuclear Medicine Preclinical Imaging Equipment Comprehensive Study by Application (Oncology, Cardiology, Neurology, Thyroid), Diagnostics (SPECT (Standalone, SPECT/CT System, SPECT/MRI System), PET (...
$ 3750